Skip to content

Zomedica Corp.

ZOMDF

CIK 0001684144

← back to feed
Revenue (TTM)
$30.36M
+17.4% YoY Q1 May 2026
Net Income (TTM)
−$81.86M
−74.2% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.09
−60.0% YoY Q1 May 2026
Gross Margin
65.9%
Q1 May 2026
Operating Margin
-277.0%
Q1 May 2026
Net Margin
-269.7%
Q1 May 2026
Free Cash Flow (TTM)
−$27.4M
Q1 May 2026
Cash
$9.37M
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
979.95M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings